91600-19-0Relevant academic research and scientific papers
ARYL CARBOXYLIC ACID CYCLOHEXYL AMIDE DERIVATIVES
-
Page/Page column 11, (2008/12/08)
A compound of formula (I) or a pharmaceutically acceptable salt or prodrug ester thereof: (I) wherein the variants R and X are defined in the specification.
CYCLIC AMINE COMPOUND AND PEST CONTROL AGENT
-
Page/Page column 30-31, (2010/11/26)
A pest control agent characterized by containing as an active ingredient a cyclic amine compound represented by the formula (1): (wherein Cy1 represents an (un)substituted five-membered heterocycle or an (un)substituted group represented by the
CYCLIC AMINE COMPOUND AND PEST CONTROL AGENT
-
Page/Page column 28-29, (2008/06/13)
A chemical compound represented by the formula [I]: (wherein R 1 represents a hydroxyl group or the like, m represents 0 or an integer of 1 to 5, R 2 represents a halogen atom or the like, k represents 0 or an integer of 1 to 4, R 3 , R 31 , R 4 , R 41 ,
QUINOLONE ANTIBACTERIAL AGENTS
-
Page/Page column 103, (2010/02/11)
Compounds of formula (I, II, III, IV, V, and VI) and methods for their preparation are disclosed. Further disclosed are methods of making biologically active compounds of formula (I) as well as pharmaceutically acceptable compositions comprising compounds of formula (I). Compounds of formula (I) as disclosed herein can be used in a variety of applications including use as antibacterial agents.
(PIPERIDINYLOXY)PHENYL, (PIPERIDINYLOXY)PYRIDINYL, (PIPERIDINYLSULFANYL)PHENYL AND (PIPERIDINYLSULFANYL)PYRIDINYL COMPOUNDS AS 5-HT1F AGONISTS
-
Page 32, (2008/06/13)
The present invention relates to compounds of formula 1: and pharmaceutically acceptable acid addition sails thereof. The compounds of the present invention are useful for activating 5-HTIF receptors, inhibiting neuronal protein extravasation, and for the treatment or preverition of migraine in mammals, particularly humans.
Tetrahydroisoquinoline derivative and medical preparation containing the same
-
, (2008/06/13)
The present invention relates to a tetrahydroisoquinoline derivative represented by the following formula 1 exhibiting an inhibitory action for agglutination caused by fibrinogen, which may be effectively used as an antithrombotic agent or a platelet agglutination-inhibiting agent. The present invention also relates to a medical preparation containing such compound. STR1 In formula 1, B and G are an alkylene optionally substituted with an alkyl or the like; D is H, an alkyl, or the like; E is 1,2,3,4-tetrahydroisoquinoline optionally substituted with R1 to R4 which binds to G at position 2; R1 to R4 are an alkyl or the like; L is hydroxy or the like; and A is a substituent represented by formula (2), and C is carbon. STR2 In formula 2, M and R5 to R8 are H, an alkyl or the like.
1-benzyl-3,5-dimethyl-4-piperdyl ester of a Hantzsch dihydropyridine
-
, (2008/06/13)
The compound of the formula STR1 is disclosed to have a less rapid decrease in blood pressure in its use as an antihypertensive.
